Emergent BioSolutions Statistics
Total Valuation
EBS has a market cap or net worth of $425.03 million. The enterprise value is $803.33 million.
| Market Cap | 425.03M |
| Enterprise Value | 803.33M |
Important Dates
The next confirmed earnings date is Thursday, April 30, 2026, after market close.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
EBS has 51.64 million shares outstanding. The number of shares has increased by 6.98% in one year.
| Current Share Class | 51.64M |
| Shares Outstanding | 51.64M |
| Shares Change (YoY) | +6.98% |
| Shares Change (QoQ) | -7.26% |
| Owned by Insiders (%) | 2.00% |
| Owned by Institutions (%) | 79.73% |
| Float | 47.00M |
Valuation Ratios
The trailing PE ratio is 8.85.
| PE Ratio | 8.85 |
| Forward PE | n/a |
| PS Ratio | 0.57 |
| Forward PS | 0.56 |
| PB Ratio | 0.82 |
| P/TBV Ratio | 4.94 |
| P/FCF Ratio | 2.71 |
| P/OCF Ratio | 2.49 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.85, with an EV/FCF ratio of 5.12.
| EV / Earnings | 15.27 |
| EV / Sales | 1.08 |
| EV / EBITDA | 3.85 |
| EV / EBIT | 6.95 |
| EV / FCF | 5.12 |
Financial Position
The company has a current ratio of 5.01, with a Debt / Equity ratio of 1.12.
| Current Ratio | 5.01 |
| Quick Ratio | 2.19 |
| Debt / Equity | 1.12 |
| Debt / EBITDA | 2.79 |
| Debt / FCF | 3.72 |
| Interest Coverage | 1.95 |
Financial Efficiency
Return on equity (ROE) is 10.46% and return on invested capital (ROIC) is 7.69%.
| Return on Equity (ROE) | 10.46% |
| Return on Assets (ROA) | 5.34% |
| Return on Invested Capital (ROIC) | 7.69% |
| Return on Capital Employed (ROCE) | 9.74% |
| Weighted Average Cost of Capital (WACC) | 10.99% |
| Revenue Per Employee | $825,444 |
| Profits Per Employee | $58,444 |
| Employee Count | 900 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 1.15 |
Taxes
In the past 12 months, EBS has paid $30.20 million in taxes.
| Income Tax | 30.20M |
| Effective Tax Rate | 36.47% |
Stock Price Statistics
The stock price has increased by +49.91% in the last 52 weeks. The beta is 2.36, so EBS's price volatility has been higher than the market average.
| Beta (5Y) | 2.36 |
| 52-Week Price Change | +49.91% |
| 50-Day Moving Average | 8.70 |
| 200-Day Moving Average | 9.58 |
| Relative Strength Index (RSI) | 47.19 |
| Average Volume (20 Days) | 614,315 |
Short Selling Information
The latest short interest is 9.64 million, so 18.67% of the outstanding shares have been sold short.
| Short Interest | 9.64M |
| Short Previous Month | 8.88M |
| Short % of Shares Out | 18.67% |
| Short % of Float | 20.52% |
| Short Ratio (days to cover) | 12.21 |
Income Statement
In the last 12 months, EBS had revenue of $742.90 million and earned $52.60 million in profits. Earnings per share was $0.93.
| Revenue | 742.90M |
| Gross Profit | 367.30M |
| Operating Income | 115.60M |
| Pretax Income | 82.80M |
| Net Income | 52.60M |
| EBITDA | 208.90M |
| EBIT | 115.60M |
| Earnings Per Share (EPS) | $0.93 |
Balance Sheet
The company has $205.40 million in cash and $583.70 million in debt, giving a net cash position of -$378.30 million or -$7.33 per share.
| Cash & Cash Equivalents | 205.40M |
| Total Debt | 583.70M |
| Net Cash | -378.30M |
| Net Cash Per Share | -$7.33 |
| Equity (Book Value) | 522.60M |
| Book Value Per Share | 10.02 |
| Working Capital | 530.30M |
Cash Flow
In the last 12 months, operating cash flow was $170.60 million and capital expenditures -$13.80 million, giving a free cash flow of $156.80 million.
| Operating Cash Flow | 170.60M |
| Capital Expenditures | -13.80M |
| Depreciation & Amortization | 93.30M |
| Net Borrowing | -112.50M |
| Free Cash Flow | 156.80M |
| FCF Per Share | $3.04 |
Margins
Gross margin is 49.44%, with operating and profit margins of 15.56% and 7.08%.
| Gross Margin | 49.44% |
| Operating Margin | 15.56% |
| Pretax Margin | 11.15% |
| Profit Margin | 7.08% |
| EBITDA Margin | 28.12% |
| EBIT Margin | 15.56% |
| FCF Margin | 21.11% |
Dividends & Yields
EBS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.98% |
| Shareholder Yield | -6.98% |
| Earnings Yield | 12.38% |
| FCF Yield | 36.89% |
Analyst Forecast
The average price target for EBS is $12.00, which is 45.81% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 45.81% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 4.68% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EBS has an Altman Z-Score of 1.49 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.49 |
| Piotroski F-Score | 7 |